This issue of the Psychiatric Clinics, edited by Dr. Peter F. Buckley, examines advances and current management in the treatment of Schizophrenia. The topics covered in this issue include, but are not limited to: Duration of Untreated Psychosis (DUP) and Longitudinal Perspectives on DUP; Neuroinflammation and Schizophrenia; Emerging Treatments for Schizophrenia; Treatment-Resistant Schizophrenia; Comorbidities and Schizophrenia; Recovery from Schizophrenia; and the latest in schizophrenia research.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 6 7. Preface: Converging Perspectives on Schizophrenia - p. 7 8. Does Biology Transcend the Symptom-based Boundaries of Psychosis? - p. 8 9. Are We Really Impacting Duration of Untreated Psychosis and Does It Matter? - p. 14 10. The Case for Adjunctive Monoclonal Antibody Immunotherapy in Schizophrenia - p. 21 11. Redefining Medication Adherence in the Treatment of Schizophrenia - p. 28 12. Update on New and Emerging Treatments for Schizophrenia - p. 38 13. Treatment-Resistant Schizophrenia - p. 50 14. Transcending Psychosis - p. 66 15. Detecting and Managing Adverse Effects of Antipsychotic Medications - p. 71 16. Recovery in Schizophrenia - p. 93 17. What Does Mental Health Parity Really Mean for the Care of People with Serious Mental Illness? - p. 104 18. What’s Hot in Schizophrenia Research? - p. 111 19. Index - p. 117
No hay muestra disponible
No hay ficha técnica disponible
This issue of the Psychiatric Clinics, edited by Dr. Peter F. Buckley, examines advances and current management in the treatment of Schizophrenia. The topics covered in this issue include, but are not limited to: Duration of Untreated Psychosis (DUP) and Longitudinal Perspectives on DUP; Neuroinflammation and Schizophrenia; Emerging Treatments for Schizophrenia; Treatment-Resistant Schizophrenia; Comorbidities and Schizophrenia; Recovery from Schizophrenia; and the latest in schizophrenia research.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 6 7. Preface: Converging Perspectives on Schizophrenia - p. 7 8. Does Biology Transcend the Symptom-based Boundaries of Psychosis? - p. 8 9. Are We Really Impacting Duration of Untreated Psychosis and Does It Matter? - p. 14 10. The Case for Adjunctive Monoclonal Antibody Immunotherapy in Schizophrenia - p. 21 11. Redefining Medication Adherence in the Treatment of Schizophrenia - p. 28 12. Update on New and Emerging Treatments for Schizophrenia - p. 38 13. Treatment-Resistant Schizophrenia - p. 50 14. Transcending Psychosis - p. 66 15. Detecting and Managing Adverse Effects of Antipsychotic Medications - p. 71 16. Recovery in Schizophrenia - p. 93 17. What Does Mental Health Parity Really Mean for the Care of People with Serious Mental Illness? - p. 104 18. What’s Hot in Schizophrenia Research? - p. 111 19. Index - p. 117
No hay muestra disponible
No hay ficha técnica disponible
